Clinical Trial Update: Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the combination of Anlotinib with chemotherapy regimens for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• DOCETAXEL (DOCETAXEL)
• Pemetrexed (pemetrexed)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: The First People's Hospital of Lianyungang | Conditions: Lung Neoplasms, Docetaxel | Phase 2 | Status: UNKNOWN